HMGB1 and inflammatory response: Thus, endothelial cells are damaged by cytotoxic release of extracellular HMGB-1, which may then act as an inflammatory mediator, thereby resulting in a pathological cycle that leads to persistent subacute chronic vascular inflammation in KD.